Category: Healthcare and Pharmaceutical

Clinical Trial Phase 1 Commemorative

Custom Lucite commemorative marking Phase 1 critical trials of guanabenz, an FDA-approved drug for high blood pressure identified as possibly effective for treatment of multiple sclerosis. The study was authored by a professor of Neurological Disorders at the University of Chicago.

1 Image

Medication Management Deal Tombstone

Deal tombstone marking the acquisition of Aesynt, a medication management company headquartered in Cranberry Township, Pennsylvania.

1 Image

Dynatronics Private Placement Tombstone

Private placement tombstone involving Dynatronics, a  physical therapy and rehabilitation marketer. The company is headquartered in Salt Lake City, Utah.

1 Image

Home Health Deal Tombstone

marking the acquisition of Atlanta-based home-health and hospice operator Gentiva Health Services by Kindred Healthcare.Kindred is headquartered in Louisville, Kentucky.

1 Image

Shield-Themed Deal Tombstone

Shield-themed deal tombstone marking an investment of growth capital in Itasca, Illinois-based Launchpoint. Launchpoint is a provider of cloud-based software and services for healthcare organizations.

1 Image

Pharma-Bioscience Deal Toy

Lucite deal toy recognizing the acquisition of Emeryville, California-based Redwood Bioscience. The acquisition was made by Catalent Pharma Solutions, headquartered in Somerset, New Jersey.

1 Image

Pill-Shaped Acrylic Tombstone

Pill-shaped Lucite tombstone commemorating a strategic investment by Gauge Capital in Veridicus Health. Based in Salt Lake City, Veridicus is a provider of comprehensive and customizable pharmacy and care management solutions.

1 Image

Research Joint Venture Commemorative

Lucite commemorative marking the joint venture between Emory University and bio-analytical testing firm Euro-Fins. The collaboration will center on Atlanta-based Emory Genetics Laboratory, which has special expertise in researching rare genetic disorders.

1 Image

Intellectual Property Agreement Commemorative

Lucite commemorative marking the acquisition of intellectual property from Interpharm Development by drug delivery firm Catalent. The agreement centers on the development of Vegicaps, a softgel capsule technology that is both all-natural and GMO free.

1 Image